2-240871540-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000030.3(AGXT):​c.524+91C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.351 in 1,203,100 control chromosomes in the GnomAD database, including 77,793 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 7523 hom., cov: 33)
Exomes 𝑓: 0.36 ( 70270 hom. )

Consequence

AGXT
NM_000030.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: -0.601

Publications

4 publications found
Variant links:
Genes affected
AGXT (HGNC:341): (alanine--glyoxylate aminotransferase) This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]
AGXT Gene-Disease associations (from GenCC):
  • alanine glyoxylate aminotransferase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • primary hyperoxaluria type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-240871540-C-T is Benign according to our data. Variant chr2-240871540-C-T is described in ClinVar as Benign. ClinVar VariationId is 204041.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.382 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000030.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGXT
NM_000030.3
MANE Select
c.524+91C>T
intron
N/ANP_000021.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGXT
ENST00000307503.4
TSL:1 MANE Select
c.524+91C>T
intron
N/AENSP00000302620.3
AGXT
ENST00000472436.1
TSL:2
n.544+91C>T
intron
N/A
AGXT
ENST00000476698.1
TSL:5
n.261+91C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.295
AC:
44875
AN:
152022
Hom.:
7526
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.436
Gnomad AMR
AF:
0.257
Gnomad ASJ
AF:
0.276
Gnomad EAS
AF:
0.241
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.396
Gnomad MID
AF:
0.312
Gnomad NFE
AF:
0.386
Gnomad OTH
AF:
0.290
GnomAD4 exome
AF:
0.359
AC:
377755
AN:
1050958
Hom.:
70270
AF XY:
0.359
AC XY:
190561
AN XY:
530940
show subpopulations
African (AFR)
AF:
0.137
AC:
3414
AN:
24936
American (AMR)
AF:
0.243
AC:
8539
AN:
35118
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
6488
AN:
22924
East Asian (EAS)
AF:
0.225
AC:
7642
AN:
34026
South Asian (SAS)
AF:
0.306
AC:
22167
AN:
72412
European-Finnish (FIN)
AF:
0.391
AC:
14792
AN:
37850
Middle Eastern (MID)
AF:
0.296
AC:
1157
AN:
3906
European-Non Finnish (NFE)
AF:
0.385
AC:
297825
AN:
773176
Other (OTH)
AF:
0.338
AC:
15731
AN:
46610
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
12661
25322
37982
50643
63304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7984
15968
23952
31936
39920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.295
AC:
44871
AN:
152142
Hom.:
7523
Cov.:
33
AF XY:
0.292
AC XY:
21736
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.141
AC:
5868
AN:
41514
American (AMR)
AF:
0.257
AC:
3927
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.276
AC:
957
AN:
3468
East Asian (EAS)
AF:
0.241
AC:
1245
AN:
5174
South Asian (SAS)
AF:
0.281
AC:
1357
AN:
4828
European-Finnish (FIN)
AF:
0.396
AC:
4196
AN:
10596
Middle Eastern (MID)
AF:
0.312
AC:
91
AN:
292
European-Non Finnish (NFE)
AF:
0.386
AC:
26223
AN:
67962
Other (OTH)
AF:
0.289
AC:
609
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1599
3198
4797
6396
7995
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.337
Hom.:
1182
Bravo
AF:
0.281
Asia WGS
AF:
0.270
AC:
943
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
1
1
Primary hyperoxaluria, type I (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.6
DANN
Benign
0.62
PhyloP100
-0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10196315; hg19: chr2-241810957; API